» Articles » PMID: 11751746

The IL-4 Production Capability of Different Strains of Naive CD4(+) T Cells Controls the Direction of the T(h) Cell Response

Overview
Journal Int Immunol
Date 2001 Dec 26
PMID 11751746
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The qualitative nature of an immune response raised against infectious pathogens depends upon the phenotypes of T(h) cell subsets, which secrete distinct types of cytokines. Genetic background is known to greatly influence the nature of the T(h) cell response. However, the precise nature of this influence still remains unclear. In the present study, we demonstrate that CD62L(+), CD44(low) and CD4(+) naive T cells from BALB/c mice are capable of producing significant amounts of IL-4, while naive T cells from B10.D2 mice exhibit no IL-4 production. The addition of exogenous IL-4 into the B10.D2 induction culture recovered T(h)2 development, thereby indicating that the potential of naive T cells to secrete IL-4 at primary activation is likely to substantially influence development of T(h)2. Regulation of the IL-4 gene in naive T cells differs from that in cells committed towards becoming T(h)2 cells, based on the observation that naive T cells from STAT6-deficient mice having a BALB/c background produce detectable amounts of IL-4. The IL-4 promoter region was found to be equally histone acetylated in both BALB/c and B10.D2 naive T cells by primary TCR activation. Interestingly, the expression levels of transcription factors NF-AT and GATA-3, which regulate promoter activity, differ between BALB/c and B10.D2 cells. These results suggest that the differences in expression level between the two transcriptional factors may affect the potential of naive T cells to secrete IL-4, which may subsequently influence the development of T(h) cell phenotypes.

Citing Articles

Rapid increase in immune surveillance and expression of NKT and γδT cell activation markers after consuming a nutraceutical supplement containing Aloe vera gel, extracts of Poria cocos and rosemary. A randomized placebo-controlled cross-over trial.

Yu L, McGarry S, Cruickshank D, Jensen G PLoS One. 2023; 18(9):e0291254.

PMID: 37699014 PMC: 10497150. DOI: 10.1371/journal.pone.0291254.


Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma.

Kandil R, Baldassi D, Bohlen S, Muller J, Jurgens D, Bargmann T J Control Release. 2023; 354:305-315.

PMID: 36634709 PMC: 7614985. DOI: 10.1016/j.jconrel.2023.01.014.


IFNγ suppresses the expression of GFI1 and thereby inhibits Th2 cell proliferation.

Sarkar M, Yagi R, Endo Y, Koyama-Nasu R, Wang Y, Hasegawa I PLoS One. 2021; 16(11):e0260204.

PMID: 34807911 PMC: 8608330. DOI: 10.1371/journal.pone.0260204.


Early Changes in Circulating Interleukins and Residual Inflammatory Risk After Acute Myocardial Infarction.

Coste M, Franca C, Izar M, Teixeira D, Ishimura M, Longo-Maugeri I Arq Bras Cardiol. 2020; 115(6):1104-1111.

PMID: 32876202 PMC: 8133737. DOI: 10.36660/abc.20190567.


T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation.

Yan J, Pandey S, Barnes B, Turner J, Abraham C Cell Rep. 2020; 31(13):107820.

PMID: 32610123 PMC: 7409536. DOI: 10.1016/j.celrep.2020.107820.